Ajanta Pharma Cash Flow Annual

BSE: 532331 | NSE: AJANTPHARM | ISIN: INE031B01049 | Sector: Biotechnology & Drugs
2,610.25 +21.90 (0.85%)Updated : 11 Jul 2025
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Issuance( Retirement)of Debt Net -13.79-16.17-14.74-16.37
Net Changein Cash 47.30-200.60124.3127.90
Cash Taxes Paid 322.97312.13151.29239.13
Net Income/ Starting Line 1,189.161,113.93745.25909.48
Total Cash Dividends Paid -349.37-642.17-89.69-82.21
Changesin Working Capital -144.04-412.22-84.77-439.52
Cashfrom Operating Activities 1,157.23785.07791.78562.04
Cash Interest Paid 17.313.532.337.35
Cashfrom Financing Activities -733.41-1,051.06-107.87-460.04
Issuance( Retirement)of Stock Net -351.33-388.270.00-285.59
Depreciation/ Depletion 144.11135.40130.80125.30
Other Investing Cash Flow Items Total -58.60217.80-385.1174.74
Capital Expenditures -317.92-152.41-174.49-148.84
period Type ----
Non- Cash Items -32.00-52.040.50-33.22
Financing Cash Flow Items -18.92-4.45-3.44-75.87
period Length 12.0012.0012.0012.00
Cashfrom Investing Activities -376.5265.39-559.60-74.10
*All figures in crores except per share values
Recommended For You
Trending Stocks
2,520.10+111.05(4.61%)
1,173.75+9.25(0.79%)
858.70+6.05(0.71%)
3,074.95-86.80 (-2.75%)